WallStreetZenWallStreetZen

NASDAQ: SONN
Sonnet Biotherapeutics Holdings Inc Stock Ownership - Who owns Sonnet Biotherapeutics Holdings?

Insider buying vs selling

Have Sonnet Biotherapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Susan DexterChief Technical Officer2023-06-1410,000$0.70
$7.00kBuy
Albert D. DyrnessDirector2023-05-3023,255$0.47
$10.88kBuy
Nailesh BhattDirector2023-05-1725,000$0.23
$5.80kBuy
Pankaj MohanChairman President and CEO2023-05-15371,600$0.22
$82.87kBuy

1 of 1

SONN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SONN insiders and whales buy or sell their stock.

SONN Shareholders

What type of owners hold Sonnet Biotherapeutics Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Michael D. Pruitt92.39%2,835,998$5.77MInsider
Larry Spitcaufsky32.46%996,258$2.03MInsider
Ics Opportunities Ltd7.24%222,222$452.22kInsider
John Markey6.07%186,430$379.39kInsider
Pankaj Mohan2.04%62,572$127.33kInsider
Renaissance Technologies LLC1.43%43,749$89.03kInstitution
John K. Cini1.31%40,271$81.95kInsider
Keith J. Johnson1.26%38,637$78.63kInsider
Susan Dexter1.10%33,667$68.51kInsider
Nailesh Bhatt1.00%30,733$62.54kInsider

1 of 3

SONN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SONN1.86%98.14%Net Buying
XBIO0.42%99.58%
SNGX0.36%99.64%
GTBP73.85%26.15%Net Buying
HOTH0.94%99.06%

Sonnet Biotherapeutics Holdings Stock Ownership FAQ

Who owns Sonnet Biotherapeutics Holdings?

Sonnet Biotherapeutics Holdings (NASDAQ: SONN) is owned by 2.96% institutional shareholders, 156.39% Sonnet Biotherapeutics Holdings insiders, and 0.00% retail investors. Michael D. Pruitt is the largest individual Sonnet Biotherapeutics Holdings shareholder, owning 2.84M shares representing 92.39% of the company. Michael D. Pruitt's Sonnet Biotherapeutics Holdings shares are currently valued at $5.76M.

If you're new to stock investing, here's how to buy Sonnet Biotherapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.